Acura Pharmaceuticals Inc (NASDAQ:ACUR)

0.8699
Delayed Data
As of Jul 07
 -0.0001 / -0.01%
Today’s Change
0.41
Today|||52-Week Range
1.35
+93.31%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$51.3M

Company Description

Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company, which is engaged in the research, development and commercialization of products intended to address medication abuse and misuse, utilizing its proprietary aversion and impede technologies. It operates its business through the research, development and manufacture of innovative abuse deterrent, orally administered pharmaceutical products. The company was founded in 1935 and is headquartered in Palatine, IL.

Contact Information

Acura Pharmaceuticals, Inc.
616 N. North Court
Palatine Illinois 60067
P:(847) 705-7709
Investor Relations:

Employees

Shareholders

Mutual fund holders2.37%
Individual stakeholders119.11%
Other institutional0.99%

Top Executives

Robert B. JonesPresident, Chief Executive Officer & Director
Peter A. ClemensCFO, Secretary, SVP & Head-Investor Relations
Albert W. BrzeczkoVice President-Technical Affairs
Robert A. SeiserTreasurer, Vice President & Controller
James F. EmighVice President-Corporate Development

To view my watchlist

Not a member yet?

Sign up now for a free account